September 2026
The cardiac marker testing market reached USD 6.01 billion in 2026, featuring leading cardiac marker testing market companies such as Abbott Laboratories, Alere Inc., bioMérieux SA.
September 2026
The global cardiac biomarkers market size reached USD 27.86 billion in 2026 and is projected to surpass around USD 82.99 billion by 2034, with a remarkable CAGR of 14.62%.
August 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
August 2025
The global cardiotoxicity screening market size is estimated to hit around USD 8.46 billion by 2034 increasing from USD 2.84 billion in 2024, with a CAGR of 11.54%.
September 2026
The global ambulatory cardiac monitoring devices market size is estimated to hit around USD 24.58 billion by 2035 increasing from USD 9.47 billion in 2026, with a CAGR of 11.19%.
September 2026
The global microbiology testing market size reached USD 6.88 billion in 2026 and is projected to be worth around USD 14.74 billion by 2035 with a CAGR of 8.85%.
September 2026
The global generative AI in testing market size was evaluated at USD 73.19 million in 2026 and is predicted to hit around USD 439.81 million by 2035, growing at a CAGR of 22.05%.
September 2026
The global genetic testing market size is calculated at USD 27.32 billion in 2026 and is projected to hit around USD 71.09 billion by 2035 with a soild CAGR of 11.26%.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The global digital biomarkers market size calculated at USD 6.19 billion in 2026 and is projected to hit around USD 36.98 billion by 2035 with a CAGR of 22.05%.
September 2026
The global genomic biomarker market size was valued at USD 6.44 billion in 2026 and is projected to reach around USD 11.63 billion by 2035, registering a notable CAGR of 6.77%.
September 2026
The rapid microbiology testing market size was USD 7.37 billion in 2026, with leading rapid microbiology testing market players including Creative Diagnostics, bioMérieux, Synbiosis, Thermo Fisher Scientific,
September 2026
The global 5G testing market size is projected to surpass around USD 8.39 billion by 2034, increasing from USD 4.46 billion in 2026, with a solid CAGR of 8.22%.
September 2026
The global automation testing market size was estimated at USD 48.88 billion in 2026 and is predicted to reach around USD 169.33 billion by 2034 with a CAGR of 16.90%.
September 2026
The biological safety testing market size was evaluated at USD 6.26 billion in 2026 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
September 2026
The global non-destructive testing equipment and services market size was evaluated at USD 9.49 billion in 2026 and is predicted to surge around USD 14.76 billion by 2035, growing at a CAGR of 5.03%.
September 2026
The biomarker discovery outsourcing services market reached USD 20.82 billion in 2026, featuring leading biomarker discovery outsourcing services market companies such as Eurofins Scientific, Charles River Laboratories, ICON plc.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The global arbovirus testing market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.16 billion by 2035, growing at a CAGR of 4.80%.
September 2026
The global pharmaceutical analytical testing market size is expected to hit around USD 22.60 billion by 2035 from USD 10.76 billion in 2026 , with a CAGR of 8.62%.
September 2026
The global enzyme-linked immunosorbent assay testing market size is estimated to hit around USD 4.41 billion by 2035 increasing from USD 2.57 billion in 2026, with a CAGR of 6.18%.
September 2026
The global preterm birth and PROM testing market size is projected to hit around USD 3.45 billion by 2034 from USD 1.82 billion in 2026 with a CAGR of 8.22%.
September 2026
The global drug of abuse testing market size was estimated at USD 15.42 billion in 2026 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
September 2026
The point of care testing market size is expected to increase from USD 49.90 billion in 2026 and is projected to hit around USD 125.33 billion by 2034 with a CAGR of 12.20%.
September 2026
The direct-to-consumer laboratory testing market size is projected to hit around USD 8.69 billion by 2035 from USD 4.08 billion in 2026 with a CAGR of 8.77%.
September 2026
The global multiplex biomarker imaging market size is projected to hit around USD 1,780.14 million by 2035 from USD 659.01 million in 2026 with a CAGR of 11.70%.
September 2026
The global cell surface marker detection market size is estimated to hit around USD 13.76 billion by 2035, increasing from USD 6.68 billion in 2026, with a CAGR of 8.37%.
September 2026
The global healthcare analytical testing services market size is estimated at USD 18.54 billion in 2026 and is expected to hit around USD 38.09 billion by 2035, growing a CAGR of 8.34% from 2026 to 2035.
September 2026
The global predictive biomarkers market size is valued at USD 34.32 billion in 2026 and is predicted to hit around USD 155.53 billion by 2035, at a CAGR of 18.34%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com